Ameliorative effects of telmisartan in diabetic rats with indomethacin-induced gastric ulceration

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 162-170

  Fouad, Amr A ^a   Al Sultan, Ali Ibrahim ^a   Yacoubi, Mohamed T ^a   Gomaa, Wafaey ^b  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Minia University   (Egypt)

Author keywords

Diabetes mellitus; Gastric ulceration; Indomethacin; Telmisartan

Indexed keywords

CASPASE 3; CATALASE; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MALONALDEHYDE; NITRIC OXIDE; PEPSIN A; SUPEROXIDE DISMUTASE; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GLYCEMIC CONTROL; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOINSULINEMIA; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PEPSIN SECRETION; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; BENZOATES; BLOOD GLUCOSE; CASPASE 3; DIABETES MELLITUS, TYPE 2; GASTRIC ACID; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; INSULIN; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953284947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.007     Document Type: Article

References (48)

1. Alumets J., Ekelund M., Hakanson R., Hedenbro J., Rehfeld J.F., Sundler F., Vallgren S. Gastric acid response to pylorus ligation in rats: is gastrin or histamine involved?. J. Physiol. 1982, 323:145-156.
2. Bech P.L., Xavier R., Lu N., Nanda N.N., Dinauer M., Podolsky D.K., Seed B. Mechanism of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000, 119:699-705.
3. Benson S.C., Pershadsingh H.A., Ho C.I., Chittiboyina A., Desai P., Pravenec M., Qi N., Wang J., Avery M.A., Kurtz T.W. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension 2004, 43:993-1002.
4. Biswas K., Bandyopadhyay U., Chattopadhyay I., Varadaraj A., Ali E., Banerjee R.K. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 2003, 278:10993-11001.
5. Blessing E., Preusch M., Kranzhöfer R., Kinscherf R., Marx N., Rosenfeld M.E., Isermann B., Weber C.M., Kreuzer J., Gräfe J., Katus H.A., Bea F. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice. Atherosclerosis 2008, 199:295-303.
6. Boehme M.W., Autschbach F., Ell C., Raeth U. Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus-a cross sectional study. Hepatogastroenterology 2007, 54:643-648.
7. Bregonzio C., Armando I., Ando H., Jezova M., Baiardi G., Saavedra J.M. Angiotensin II AT1 receptor blockade prevents gastric ulcers during cold-restraint stress. Ann. N.Y. Acad. Sci. 2004, 1018:351-355.
8. Brzozowska I., Targosz A., Sliwowski Z., Kwiecien S., Drozdowicz D., Pajdo R., Konturek P.C., Brzozowski T., Pawlik M., Konturek S.J., Pawlik W.W., Hahn E.G. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J. Physiol. Pharmacol. 2004, 55:773-790.
9. Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003, 24:471-478.
10. Carl-McGrath S., Grantzdorffer I., Lendeckel U., Ebert M.P., Rocken C. Angiotensin II-generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H. pylori and associated cytokines. Pathology 2009, 41:419-427.
11. Faubion W.A., Gores G.J. Death receptors in liver biology and pathobiology. Hepatology 1999, 29:1-4.
12. Gao Y., Zhou S., Wen J., Huang M., Xu A. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci. 2002, 72:731-745.
13. Goldin E., Ardite E., Elizalde J.I., Odriozola A., Panés J., Piqué J.M., Fernández-Checa J.C. Gastric mucosal damage in experimental diabetes in rats: role of endogenous glutathione. Gastroenterology 1997, 112:855-863.
14. Gomaa W., Ke Y., Fujii H., Helliwell T. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Arch. 2005, 447:701-709.
15. Goyal B.R., Mesariya P., Goyal R.K., Mehta A.A. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Mol. Cell. Biochem. 2008, 314:123-131.
16. Hara N., Hara Y., Natsume Y., Goto Y. Gastric hyperacidity and mucosal damage caused by hypothermia correlate with increase in GABA concentrations of the rat brain. Eur. J. Pharmacol. 1991, 194:77-81.
17. Hasegawa G., Fukui M., Hosoda H., Asano M., Harusato I., Tanaka M., Shiraishi E., Senmaru T., Sakabe K., Yamasaki M., Kitawaki J., Fujinami A., Ohta M., Obayashi H., Nakamura N. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male spontaneously diabetic Torii rats. Eur. J. Pharmacol. 2009, 605:164-169.
18. Hawkins C., Hanks G.W. The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature. J. Pain Symptom Manage. 2000, 20:140-151.
19. 1 receptor antagonist, on rat gastric mucosal blood flow. Aliment. Pharmacol. Ther. 1999, 13:347-355.
20. Hung C.R. Effect of lysozyme chloride on betel quid chewing aggravated gastric oxidative stress and hemorrhagic ulcer in diabetic rats. World J. Gastroenterol. 2005, 11:5853-5858.
21. Iwai K., Kim M.Y., Onodera A., Matsue H. Physiological effects and active ingredients of Viburnum dilatatum Thunb fruits on oxidative stress. Biofactors 2004, 21:273-275.
22. Jung K.H., Chu K., Lee S.T., Kim S.J., Song E.C., Kim E.H., Park D.K., Sinn D.I., Kim J.M., Kim M., Roh J.K. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J. Pharmacol. Exp. Ther. 2007, 322:1051-1058.
23. Kaschina E., Schrader F., Sommerfeld M., Kemnitz U.R., Grzesiak A., Krikov M., Unger T. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. J. Hypertens. 2008, 26:2361-2373.
24. Kobayashi N., Ohno T., Yoshida K., Fukushima H., Mamada Y., Nomura M., Hirata H., Machida Y., Shinoda M., Suzuki N., Matsuoka H. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Am. J. Hypertens. 2008, 21:576-581.
25. Konturek P.C., Brzozowski T., Kania J., Kukharsky V., Bazela K., Kwiecien S., Harsch I., Konturek S.J., Hahn E.G. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat. Scand. J. Gastroenterol. 2003, 38:468-476.
26. Korolkiewicz R., Tashima K., Kubomi M., Kato S., Takeuchi K. Increased susceptibility of diabetic rat gastric mucosa to food deprivation during cold stress. Digestion 1999, 60:528-537.
27. Liu P., Hock C.E., Nagele R., Wong P.Y. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion. Am. J. Physiol. 1997, 272:2327-2336.
28. Martin G.R., Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp. Biol. Med. 2006, 231:130-137. (Maywood).
29. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998, 47:224-229.
30. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am. J. Physiol. 1983, 245:G601-G623.
31. Mohan Kumar M., Joshi M.C., Prabha T., Dorababu M., Goel R.K. Effect of plantain banana on gastric ulceration in NIDDM rats: role of gastric mucosal glycoproteins, cell proliferation, antioxidants and free radicals. Indian J. Exp. Biol. 2006, 44:292-299.
32. 2+ channel expression in neonatal rat cardiomyocytes. Eur. J. Pharmacol. 2009, 609:105-112.
33. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 1994, 266:E829-E839.
34. Morsy M., Ashour O., Amin E., Rofaeil R. Gastroprotective effects of telmisartan on experimentally-induced gastric ulcers in rats. Pharmazie 2009, 64:590-594.
35. Morsy M.A., Ashour O.M., Fouad A.A., Abdel-Gaber S.A. Gastroprotective effects of the insulin sensitizers, rosiglitazone and metformin, in indomethacin-induced gastric ulcer in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2010, 37:173-177.
36. Nakamura T., Keep R.F., Hua Y., Hoff J.T., Xi G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res. 2005, 1039:30-36.
37. Pavel J., Benicky J., Murakami Y., Sanchez-Lemus E., Saavedra J.M. Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo. Ann. N.Y. Acad. Sci. 2008, 1148:360-366.
38. Perdichizzi G., Bottari M., Pallio S., Fera M.T., Carbone M., Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol. 1996, 19:149-154.
39. Pietzsch M., Theuer S., Haase G., Plath F., Keyser M., Riethling A.K. Results of systematic screening for serious gastrointestinal bleeding associated with NSAIDs in Rostock hospitals. Int. J. Clin. Pharmacol. Ther. 2002, 40:111-115.
40. Rainsford K.D., Whitehouse M.W. Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem. Pharmacol. 1980, 29:1281-1289.
41. Sanyal A.R., Denath O.K., Bhattacharya S.K., Gode K.D. The effect of cyproheptadine on gastric acidity. Peptic Ulcer 1971, 312-318. Scandinavian University Books, Munksgaard, Copenhagen. C.J. Pfeiffer (Ed.).
42. Takaya T., Kawashima S., Shinohara M., Yamashita T., Toh R., Sasaki N., Inoue N., Hirata K., Yokoyama M. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis 2006, 186:402-410.
43. Takehara K., Tashima K., Takeuchi K. Alterations in duodenal bicarbonate secretion and mucosal susceptibility to acid in diabetic rats. Gastroenterology 1997, 112:418-428.
44. Tashima K., Korolkiewicz R., Kubomi M., Takeuchi K. Increased susceptibility of gastric mucosa to ulcerogenic stimulation in diabetic rats-role of capsaicin-sensitive sensory neurons. Br. J. Pharmacol. 1998, 124:1395-1402.
45. Tashima K., Fujita A., Takeuchi K. Aggravation of ischemia/reperfusion-induced gastric lesions in streptozotocin-diabetic rats. Life Sci. 2000, 67:1707-1718.
46. Welch W.J. Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. Hypertension 2008, 52:51-56.
47. Winzler R.J. Determination of serum glycoproteins. Methods Biochem. Anal. 1955, 2:279-311.
48. Zhang X., Tajima K., Kageyama K., Kyoi T. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J. Gastroenterol. 2008, 14:4784-4790.